Skip to main content
Log in

Understanding auto-immune encephalitis in the ICU

  • Understanding the Disease
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Venkatesan A, Tunkel AR, Bloch KC et al (2013) Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis 57:1114–1128. https://doi.org/10.1093/cid/cit458

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Venkatesan A, Michael BD, Probasco JC et al (2019) Acute encephalitis in immunocompetent adults. Lancet 393:702–716. https://doi.org/10.1016/S0140-6736(18)32526-1

    Article  PubMed  Google Scholar 

  3. Dalmau J, Graus F (2018) Antibody-mediated encephalitis. N Engl J Med 378:840–851. https://doi.org/10.1056/NEJMra1708712

    Article  PubMed  Google Scholar 

  4. Jeannin-Mayer S, André-Obadia N, Rosenberg S et al (2019) EEG analysis in anti-NMDA receptor encephalitis: description of typical patterns. Clin Neurophysiol 130:289–296. https://doi.org/10.1016/j.clinph.2018.10.017

    Article  CAS  PubMed  Google Scholar 

  5. Probasco JC, Solnes L, Nalluri A et al (2017) Abnormal brain metabolism on FDG-PET/CT is a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 11:e352. https://doi.org/10.1212/NXI.0000000000000352

    Article  PubMed  Google Scholar 

  6. Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391–404. https://doi.org/10.1016/S1474-4422(15)00401-9

    Article  PubMed  PubMed Central  Google Scholar 

  7. Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157–165. https://doi.org/10.1016/S1474-4422(12)70310-1

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Viaccoz A, Desestret V, Ducray F et al (2014) Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 82:556–563. https://doi.org/10.1212/WNL.0000000000000126

    Article  CAS  PubMed  Google Scholar 

  9. Armangue T, Spatola M, Vlagea A et al (2018) Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol 17:760–772. https://doi.org/10.1016/S1474-4422(18)30244-8

    Article  PubMed  PubMed Central  Google Scholar 

  10. Sonneville R, Demeret S, Klein I et al (2008) Acute disseminated encephalomyelitis in the intensive care unit: clinical features and outcome of 20 adults. Intensive Care Med 34:528–532. https://doi.org/10.1007/s00134-007-0926-2

    Article  PubMed  Google Scholar 

  11. de Montmollin E, Demeret S, Brulé N et al (2017) Anti-N-methyl-d-aspartate receptor encephalitis in adult patients requiring intensive care. Am J Respir Crit Care Med 195:491–499. https://doi.org/10.1164/rccm.201603-0507OC

    Article  PubMed  Google Scholar 

  12. Lancaster E (2016) The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol 12:1–13. https://doi.org/10.3988/jcn.2016.12.1.1

    Article  PubMed  Google Scholar 

  13. Scheibe F, Prüss H, Mengel AM et al (2017) Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis. Neurology 88:366–370. https://doi.org/10.1212/WNL.0000000000003536

    Article  CAS  PubMed  Google Scholar 

  14. Cohen J, Sotoca J, Gandhi S et al (2019) Autoimmune encephalitis: a costly condition. Neurology. https://doi.org/10.1212/WNL.0000000000006990.10.1212/WNL.0000000000006990

    Article  PubMed  PubMed Central  Google Scholar 

  15. Sonneville R, Mariotte E, Neuville M et al (2016) Early-onset status epilepticus in patients with acute encephalitis. Medicine 95:e4092. https://doi.org/10.1097/MD.0000000000004092

    Article  PubMed  PubMed Central  Google Scholar 

  16. Geis C, Planagumà J, Carreño M et al (2019) Autoimmune seizures and epilepsy. J Clin Investig 129:926–940. https://doi.org/10.1172/JCI125178

    Article  PubMed  PubMed Central  Google Scholar 

  17. de Bruijn MAAM, van Sonderen A, van Coevorden-Hameete MH et al (2019) Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis. Neurology 92:e2185–e2196. https://doi.org/10.1212/WNL.0000000000007475

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Lejuste F, Thomas L, Picard G et al (2016) Neuroleptic intolerance in patients with anti-NMDAR encephalitis. Neurol Neuroimmunol Neuroinflamm 3:e280. https://doi.org/10.1212/NXI.0000000000000280

    Article  PubMed  PubMed Central  Google Scholar 

  19. Schubert J, Brämer D, Huttner HB et al (2019) Management and prognostic markers in patients with autoimmune encephalitis requiring ICU treatment. Neurol Neuroimmunol Neuroinflamm 6:e514. https://doi.org/10.1212/NXI.0000000000000514

    Article  PubMed  Google Scholar 

  20. Balu R, McCracken L, Lancaster E et al (2019) A score that predicts 1 year functional status in patients with anti-NMDA receptor encephalitis. Neurology 92:e244–e252. https://doi.org/10.1212/WNL.0000000000006783

    Article  PubMed  PubMed Central  Google Scholar 

  21. Mittal MK, Rabinstein AA, Hocker SE et al (2016) Autoimmune encephalitis in the ICU: analysis of phenotypes, serologic findings, and outcomes. Neurocrit Care 24:240–250. https://doi.org/10.1007/s12028-015-0196-8

    Article  CAS  PubMed  Google Scholar 

  22. Wells E, Hacohen Y, Waldman A et al (2018) Neuroimmune disorders of the central nervous system in children in the molecular era. Nat Rev Neurol 14:433–445. https://doi.org/10.1038/s41582-018-0024-9

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Sonneville.

Ethics declarations

Conflicts of interest

RS received grants from the French Ministry of Health, the French society of intensive care medicine (SRLF) and the European society of intensive care medicine (ESICM), and lecture fees from Baxter. The other authors declare that they have no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sonneville, R., Venkatesan, A. & Honnorat, J. Understanding auto-immune encephalitis in the ICU. Intensive Care Med 45, 1795–1798 (2019). https://doi.org/10.1007/s00134-019-05773-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-019-05773-0

Navigation